In glioma stem-like cells, which are generally resistant to conventional therapy, autophagy plays a critical role in stemness, and G9a acts on the promoters of genes associated with autophagy (MAP1LC3B and WIPI1) and differentiation (GFAP and TUBB3). Here, EHMT2 is linked to glioma.